UPC CoA 237/2025

Vor dem UPC: Juul Labs Group (33 Verfahren)·Altria Group (45 Verfahren)

• 2026-01-09
  Withdrawal (RoP265)Öffentlich

  Zusammenfassung: The Court of Appeal permitted Juul Labs International, Inc. to withdraw its appeal against the Central Division Paris revocation decision (UPC_CFI_316/2023, 17 January 2025), which had revoked EP 3 430 921 across multiple UPC member states. The withdrawal was prompted by the EPO Boards of Appeal dismissing Juul Labs' appeal on 20 October 2025, confirming the patent's revocation by the EPO Opposition Division (decision of 10 September 2024). NJOY had no legitimate interest in the appeal being decided. Court fees were reimbursed under the pre-2026 rate.

  Rechtsfragen anzeigen (3)

  • Withdrawal of appeal under R.265 RoP
  • Reimbursement of court fees under R.370.9 RoP
  • Effect of EPO Boards of Appeal decision on UPC proceedings
• 2025-04-28
  Öffentlich

  Zusammenfassung: The UPC Court of Appeal granted Juul Labs International's application to stay the revocation appeal proceedings pending a final decision by the EPO Boards of Appeal in parallel opposition proceedings concerning EP3430921, noting that both parties agreed to the stay and that the EPO oral proceedings were scheduled for approximately the same time as the UPC appeal hearing.

  Rechtsfragen anzeigen (4)

  • Stay of proceedings pending EPO opposition appeal (R.295 RoP)
  • Meaning of 'rapid decision' in R.295(a) RoP
  • Consent of both parties to stay
  • Accelerated EPO proceedings
• 2025-04-25
  Application RoP262.1 (b)Öffentlich

  Zusammenfassung: The Court of Appeal granted a member of the public (Nicoventures) immediate access to written pleadings and evidence under R. 262.1(b) RoP, subject to conditions restricting use of those documents in other proceedings until the appeal is resolved.

  Rechtsfragen anzeigen (4)

  • Public access to written pleadings
  • R. 262.1(b) RoP
  • Admissibility of access requests
  • Conditions on access